Application of a Bayesian Adaptive Randomization Design to Optimize Intravenous Ketamine Dosing for Late-Life Treatment-Resistant Depression
NEUROPSYCHOPHARMACOLOGY（2021）
Key words
Ketamine, Treatment-Resistant Late Life Depression, Neuropsychiatry, Clinical Trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined